Projects
-
DYSTRO-SMARTY: La plataforma de Nanomedicina para terapias avanzadas contra lasvDistrofias Musculares Congénitas.
- Leader
- Cecilia Jiménez Mallebrera
- Announcement
- Conveni
- Code
- PCP00358
- Starting date
- 2023
- End date
- 2024
- Funded by
- Fundación Salud 2000 (Merck Salud)
-
Estudio de la historia natural de la artrogriposis múltiple congénita
- Leader
- Andrés Nascimento Osorio
- Announcement
- Covocatoria de Proyectos Investigación
- Code
- PCP00375
- Starting date
- 2023
- End date
- 2024
- Funded by
- Associació Muevete por los que no pueden
-
MyoQ: La Plataforma de Nanomedicina para terapias avanzadas contra las Distrofias Musculares Congénitas.
- Leader
- Cecilia Jiménez Mallebrera
- Announcement
- Proves de validació
- Code
- SLT033/23/000032
- Starting date
- 2023
- End date
- 2024
- Funded by
- Generalitat de Catalunya
-
EBRAINS PREP
- Leader
- Cecilia Jiménez Mallebrera
- Announcement
- HORIZON-INFRA-2021-DEV-02
- Code
- 101079717
- Starting date
- 2022
- End date
- 2025
- Funded by
- European Commission
-
Cohort of Spanish Patients with Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
- Leader
- Carlos Ignacio Ortez Gonzalez
- Announcement
- Conveni
- Code
- PCP00337
- Starting date
- 2022
- End date
- 2024
- Funded by
- PTC Therapeutics International Limited
-
DYSTRO-SMARTY: A novel nanotechnology platform for delivery of nucleic acids to treat Collagen VI-related Congenital Muscular Dystrophy
- Leader
- Cecilia Jiménez Mallebrera
- Code
- PFNR0160
- Starting date
- 2022
- End date
- 2023
- Funded by
- Fundación Noelia. Niños Contra la Distrofia Muscular Congénita por Déficit de Colágeno VI
-
Movilidad de profesionales sanitarios e investigadores del SNS (M-BAE)
- Leader
- Cecilia Jiménez Mallebrera
- Announcement
- M-BAE
- Code
- BA21/00010
- Starting date
- 2022
- End date
- 2022
- Funded by
- Instituto de Salud Carlos III (ISCIII)
-
Spinal muscular atrophy disease registry
- Leader
- Andrés Nascimento Osorio
- Announcement
- Convenio
- Code
- PCP00323
- Starting date
- 2021
- End date
- 2026
- Funded by
- Novartis Farmacéutica, S.A
-
ArmTracker: A state-of-the-art wearable system to assess upper limb motor function in reallife conditions for patients with Duchenne muscular dystrophy and spinal muscular atrophy.
- Leader
- Daniel Natera de Benito
- Announcement
- Projectes de recerca en malalties minoritàries
- Code
- 561/C/2020
- Starting date
- 2021
- End date
- 2024
- Funded by
- Fundació La Marató de TV3
-
Emerging biomarkers for spinal muscular atrophy
- Leader
- Cecilia Jiménez Mallebrera
- Announcement
- Biogen
- Code
- ES-SPN-1188
- Starting date
- 2021
- End date
- 2023
- Funded by
- Biogen International GmbH